Public hearing 6: Psychotropic medication, behaviour support and behaviours of concern
The Royal Commission held Public hearing 6 in Sydney from 22 to 25 September 2020.
This hearing examined the use of psychotropic medication to address behaviours of concern exhibited by people with disability.
When a person with disability engages in behaviours that put themselves and/or others at risk of harm, this is referred to as ‘behaviours of concern’. Psychotropic medication is an umbrella term used to refer to any drug capable of affecting the mind, emotions or behaviour. Among the types of psychotropic drugs are anti-psychotics, anti-depressants, and mood stabilisers.
Among the issues that were examined at the hearing were:
the extent of use of psychotropic medication to address behaviours of concern, and the effects that medication can have on the health and wellbeing of people with disability
the regulatory frameworks for the use of psychotropic medication as a chemical restraint, a form of restrictive practice
how the restrictive practices regulatory frameworks in Queensland operate in practice with respect to the use of psychotropic medication
the intersection between health and disability services in addressing behaviours of concern exhibited by a person with disability
alternatives to psychotropic medication, particularly behaviour support.